Astria Therapeutics (ATXS) Profit After Tax: 2013-2018
Historic Profit After Tax for Astria Therapeutics (ATXS) over the last 6 years, with Dec 2018 value amounting to -$25.9 million.
- Astria Therapeutics' Profit After Tax fell 10.24% to -$6.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$25.9 million, marking a year-over-year increase of 5.46%. This contributed to the annual value of -$25.9 million for FY2018, which is 5.46% up from last year.
- According to the latest figures from FY2018, Astria Therapeutics' Profit After Tax is -$25.9 million, which was up 5.46% from -$27.4 million recorded in FY2017.
- Astria Therapeutics' 5-year Profit After Tax high stood at -$21.9 million for FY2014, and its period low was -$36.1 million during FY2016.
- Its 3-year average for Profit After Tax is -$29.8 million, with a median of -$27.4 million in 2017.
- In the last 5 years, Astria Therapeutics' Profit After Tax plummeted by 49.10% in 2015 and then increased by 24.12% in 2017.
- Astria Therapeutics' Profit After Tax (Yearly) stood at -$21.9 million in 2014, then crashed by 49.10% to -$32.6 million in 2015, then declined by 10.51% to -$36.1 million in 2016, then increased by 24.12% to -$27.4 million in 2017, then rose by 5.46% to -$25.9 million in 2018.